NL-OMON36574已完成不适用
Assessment of tumor hypoxia during radiotherapy course in locally advanced Head and Neck cancer with 18F-fluoroazomycin arabinoside (18F-FAZA)-PET-CT - FAZA pilot study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational non invasive
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •* Intended curative primary (chemo)radiation for patients with locally advanced HNSCC.
- •* Age * 18 years.
- •* WHO performance status 0-2 (see appendix 1)
- •* Histological of cytological confirmation of HNSCC
- •* Locally advanced HNSCC (stage III-IV), TNM classification [8]
- •* Staging procedure should at least include CT-neck, MRI-neck and 18F-FDG-PET-scan
- •* Life expectancy of at least 6 months
- •* Planned for 35 x 2 Gy IMRT eventually with concomitant chemotherapy
- •* Absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; those conditions should be discussed with the patient before registration in the trial.
- •* Before patient registration/randomisation, written informed consent must be given according to ICH/EU GCP, and national/local regulations.
排除标准
- •Not fullfilling the inclusioncriteria
研究者
相似试验
已完成
不适用
Evaluation of tumor hypoxia for stereotactic radiotherapy using F-18 fluoromisonidazoleung cancerJPRN-UMIN000028332Kindai University15
已完成
不适用
Assessment of Hypoxia Before Radioembolization Treatment With 18F-FMISO PETRadioembolizationRadiotherapyPositron Emission TomographyCancerNCT06027021Ankara University64
撤回
不适用
A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZAHypoxic TumoursNCT00756691AHS Cancer Control Alberta
尚未招募
不适用
The significance of changes in tumor hypoxia by anti-PD-1 / PD-L1 antibody therapy for advanced non-small cell lung cancer.advanced non-small cell lung cancerJPRN-UMIN000041659Saitama Medical University International Medical Center20
尚未招募
2 期
Validation of hypoxia imaging of cancer in the head and neck area with FAZA-PEToropharyngeal cancerNL-OMON32369Antoni van Leeuwenhoek Ziekenhuis20